Atlas Trials

CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs

Clinical trial NCT07172256 · RECRUITING

Trial details

NCT number
NCT07172256
Sponsor
Yale University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell CarcinomaNew Diagnosis TumorLocally Advanced
Start date
2026-05-07
Primary completion
2031-02-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.